As of yesterday, the XBI biotech index has not only reversed last month’s slump but reached the full-year high it set in April. And that’s despite the fact that drug pricing rhetoric has hardly subsided, and next year’s presidential election remains as unpredictable as ever.
Image: https://mailchi.mp
{iframe}https://mailchi.mp/statnews/pelosis-pricing-plan-the-costliest-peanut-crispring-to-save-a-sibling-597429?e=ce32a7cae6{/iframe}